Lupus is a chronic autoimmune condition with devastating effects, predominantly on women between the ages of 15-45.
Inability to diagnose the disease early, understand its progression, and predict periodic flare-ups results in irreversible organ damage and death. Progentec's biomarker-based platform offers multiple tests to manage various facets of the disease ranging from diagnosis to disease tracking and flare prediction - these come with a suite of digital health solutions. Progentec is thus uniquely positioned to bring about novel ways to engage patients and other stakeholders and deliver better clinical and economic outcomes.
of Lupus Warriors WANT TO BETTER UNDERSTAND HOW THEIR DISEASE CHANGES OVER TIME
of Lupus Warriors DON’T KNOW HOW THEIR TREATMENT TEAM MEASURES DISEASE ACTIVITY
"We've made tremendous progress in developing a tool for the identification of lupus flare-ups before they occur."
Mohan Purushothaman, CEO
